Theratechnologies Inc
TSX:TH
Theratechnologies Inc
TSX:TH
Price:
1.66 CAD
Market Closed
Updated:
May 14, 2024
Theratechnologies Inc
Research & Development
|
Theratechnologies Inc
Research & Development Peer Comparison
Comparables:
ZYME
RPTX
FUSN
AUPH
EDT
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Theratechnologies Inc
TSX:TH
|
Research & Development
-$24.8m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-14%
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Research & Development
-$143.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Research & Development
-$131.8m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-69%
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Research & Development
-$70.1m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Research & Development
-$42m
|
CAGR 3-Years
3%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-32%
|
|
|
Spectral Medical Inc
TSX:EDT
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Theratechnologies Inc's Research & Development?
Research & Development
-24.8m
USD
-24.8m
USD
Based on the financial report for Feb 29, 2024, Theratechnologies Inc's Research & Development amounts to -24.8m USD.
What is Theratechnologies Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-14%
-14%
Over the last year, the Research & Development growth was 35%. The average annual Research & Development growth rates for Theratechnologies Inc have been -8% over the past three years , -24% over the past five years , and -14% over the past ten years .
You don't have any saved screeners yet
